Peter Coffey

Institute of Ophthalmology, University College London

Coffey’s key achievements include being an author of a seminal retinal transplantation publication, and being the principal author and co-author, respectively, of two landmark papers that described the use of human stem cells to halt visual deterioration in animal models of AMD. His work includes the use of human embryonic stem cells for treatment of macular degeneration and retinitis pigmentosa, and the development of a stem cell-based therapy for dry AMD. He is currently the director of the London Project at Moorfields Eye Hospital, which performs clinical trials of stem cell therapies for the treatment of AMD.

Part of the Power List 2016

Welcome to The Power List 2016 – our second foray into the Top 100 most influential people in the world of ophthalmology.

Though we realize our list can (and should) never be definitive, who can argue that the faces within – both familiar and new – do not beautifully highlight the brilliance and diversity found within the field?

Here, we celebrate 100 reasons to be proud of ophthalmology.

Go to The Power List 2016